Physician profile
Steven Zhou
NPI 1952862450
$11,323.57
in general payments reported to CMS, 2019-2025
8 companies · $525 in 2025
The $525 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $7,758 · 2024: $3,041 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,308 · Food and Beverage: $3,500 · Grant: $2,500 · Education: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,307.60 |
| Food and Beverage | $3,499.82 |
| Grant | $2,500.00 |
| Education | $1,016.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,286.39 | 2023-2025 | Synchromedii, Vanta Adaptivestim, Intellis Adaptivestim |
| Boston Scientific Corporation | $2,941.73 | 2023-2025 | Vercise, Intracept, Ams 700 |
| Nevro Corp. | $2,192.83 | 2023 | Senza |
| Abbott Laboratories | $511.71 | 2024 | Proclaim |
| Abbvie INC. | $146.77 | 2023 | Botox |
| Vertos Medical, INC. | $116.02 | 2024 | Mild Device Kit |
| Spr Therapeutics, INC | $79.03 | 2024 | Sprint Pns System |
| Stryker Corporation | $49.09 | 2025 | Spinejack, Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Zhou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.